A new form of amyloid has become recognized as a serious complication of long term hemodialysis (1) (2) (3) (4) . Its most prominent clinical presentation is the carpal tunnel syndrome (5) . Its incidence correlates mainly with the number of years spent on dialysis (6) . Other manifestations include joint swelling and hemarthrosis (7) ; multiple, spontaneous fractures (8) ; and radiolucency in the wrist and hip (9) . Symptoms increase with increasing time on dialysis.
Beta2 microglobulin (132M) is the principal constituent of the amyloid deposits isolated from these patients (10, 11) .
It is a single polypeptide chain of 11,800 MW, made of 100 amino acids residues (12) and associated with HLA antigens on cell membranes (13, 14) . Viable lymphoid cells produce 132M at a rate estimated to exceed 25 molecules 132M per second. Free 13 2 M is almost completely filtered by the glomeruli and is subsequently reabsorbed and catabolized by the proximal tubular cells. A normal kidney is able to reabsorb almost all the 132M, so the urinary excretion is usually below 370 jlg/24 hours. Increased urinary excretion usually results from a malfunction of the proximal tubule (15) . 132M levels rise progressively in patients with chronic renal failure, and these levels correlate closely with serum creatinine levels (16) . The half-life of B2M in the intravascular compartment varies from 107 min in a normal patient to more than 39 hours in an anephric patient.
132M accumulates not only in the blood of uremic patients (17) but also in the synovial fluid and in the tissues (18) . Elevated 132M levels suggest a correlation with the development of dialysis amyloid. Amino acid sequence analysis support the hypothesis that the main constituent of the amyloid found in dialysis patients is almost entirely 132M. Immunohistochemical studies have also confirmed this hypothesis; and in vitro studies have, shown formation of amyloid fibrils from intact 132M (19) . Amyloid deposits have been The International Journal Of Artificial Organs / Vol. 11 / no. 4, 1988·/ pp. 229-231 found in the heart, spleen, kidney, and prostate of hemodialysis patients (20, 21) .
The pathogenesis of dialysis amyloidosis is poorly understood. It is possible that dialysis membrane characteristics may playa role (22) . Because of complement activation and interleukin production during hemodialysis with cuprophane and cellulose acetate membranes increased 132M production has been hypothesized. Several investigators have found increased production (23, 24) , but others (25, 26) membranes remove 132M during dialysis; the one has an increased sieving coefficient, the other increases adsorption. In either case the postdialysis levels decrease by 40 to 50%. Yet we have observed that after 6 months of dialysis with polysulfone membranes the predialysis levels of 132M have remained unchanged.
Fischbach (29) has also found this to be true in children dialyzed for 5 years with PAN or polysulfone membrane. These preliminary results are not very promising. EVidently, daily production of 13 2 M exceeds its removal. The implications of 132M removal by these more permeable membranes remains to be clarified. The peritoneum also removes 132M. The mean amount of 132M in the peritoneal dialysate fluid of our patients was 6.7 ± 2.6 mg/L, and their estimated 24hour losses were 80.4 mg. In spite of these peritoneal losses, there is disagreement about serum levels of 132M in continuous ambulatory peritoneal dialysis (CAPD). Some investigators have found that serum levels of 132M were lower in CAPD patients than in hemodialysis patients (15) but others have found no significant difference (30) . Dialysis-associated amyloidosis has not been described in patients treated only by CAPD, but a longer period of observation and a larger number of patients is needed. Thus the benefits of 132M removal by more permeable membranes or by the peritoneum need to be further investigated.
Another attractive possibility for removing 132M is renal transplantation. Patients who receive a successful kidney transplant rapidly normalize their serum levels of 132M. Large amounts of 132M are excreted in the urine, especially during the first day after transplantation. When we correlate the amount excreted in
